Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft - Bertin Instruments

    Scientific publications

    Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft

    Kevin S. Chu a, Warefta Hasan b, a, Sumit Rawal a, Mark D. Walsh a, Elizabeth M. Enlow b, J. Christopher Luft b, c, Arlene S. Bridges d, Jennifer L. Kuijer a, Mary E. Napier b, c, e, William C. Zamboni a, c, f, g, h, Joseph M. DeSimone a, b, c, g, h, i, j, k, l
    Sources: a Department of Pharmaceutical Sciences, University of North Carolina; b Department of Chemistry, University of North Carolina; c Lineberger Comprehensive Cancer Center, University of North Carolina; d Department of Pathology and Lab Medicine, University of North Carolina; e Department of Biochemistry and Biophysics, University of North Carolina; f Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina; g Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina; h Department of Pharmacology,, Eshelman School of Pharmacy, University of North Carolina; i Institute for Nanomedicine, University of North Carolina; j Institute for Advanced Materials, University of North Carolina; k Department of Chemical and Biomolecular Engineering, North Carolina State University; l Sloan-Kettering Institute for Cancer research,, Memorial Sloan-Kettering Cancer Center
    Nanomedicine: Nanotechnology, Biology and Medicine, Available online 6 December 2012http://dx.doi.org/10.1016/j.nano.2012.11.008, How to Cite or Link Using DOI

    Sample name

    Animal tissues (mice)

    Kits

    CKMix_2mL

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question